Qingdao Haier Biomedical Co.,Ltd Share Price
Equities
688139
CNE100003P25
Advanced Medical Equipment & Technology
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 31.49 CNY | -0.51% |
|
-4.14% | -0.91% |
| Capitalization | 9.79B 1.42B 1.22B 1.1B 1.06B 1.92B 131B 2.01B 13.03B 5.23B 62.45B 5.32B 5.21B 224B | P/E ratio 2025 |
39.7x | P/E ratio 2026 * | 18.4x |
|---|---|---|---|---|---|
| Enterprise value | 9.79B 1.42B 1.22B 1.1B 1.06B 1.92B 131B 2.01B 13.03B 5.23B 62.45B 5.32B 5.21B 224B | EV / Sales 2025 |
4.26x | EV / Sales 2026 * | 3.15x |
| Free-Float |
49.58% | Yield 2025 * |
-
| Yield 2026 * | - |
| 1 day | -0.51% | ||
| 1 week | -4.14% | ||
| Current month | -4.14% | ||
| 1 month | -2.84% | ||
| 3 months | -1.62% | ||
| 6 months | -6.00% | ||
| Current year | -0.91% |
| 1 week | 30.92 | 32.56 | |
| 1 month | 30.92 | 33.29 | |
| Current year | 30.92 | 38.8 | |
| 1 year | 29.68 | 38.8 | |
| 3 years | 23.96 | 75.5 | |
| 5 years | 23.96 | 150.88 | |
| 10 years | 23.87 | 150.88 |
| Manager | Title | Age | Since |
|---|---|---|---|
Zhan Jie Liu
CEO | Chief Executive Officer | 56 | 27/10/2005 |
Rui Juan Mo
DFI | Director of Finance/CFO | 45 | 31/12/2018 |
Guang Sheng Wang
PRN | Corporate Officer/Principal | 54 | 31/12/2018 |
| Director | Title | Age | Since |
|---|---|---|---|
Zhan Jie Liu
BRD | Director/Board Member | 56 | 27/10/2005 |
Li Xia Tan
CHM | Chairman | 56 | 31/05/2018 |
Yun Jie Zhou
BRD | Director/Board Member | 59 | 31/05/2018 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.51% | -4.14% | -8.27% | -53.46% | 1.43B | ||
| +0.20% | -1.40% | -4.81% | -9.36% | 186B | ||
| -0.27% | -1.96% | +0.81% | +112.85% | 174B | ||
| +0.85% | -4.65% | -4.29% | -19.37% | 138B | ||
| +0.78% | -5.96% | -23.85% | +52.32% | 106B | ||
| -1.01% | -3.31% | -22.99% | -21.78% | 52.29B | ||
| +2.45% | -4.42% | +21.59% | +9.59% | 47.42B | ||
| -0.17% | -2.07% | +6.52% | +18.83% | 36.67B | ||
| +0.63% | -7.10% | -12.76% | -2.51% | 33.85B | ||
| +0.46% | -2.34% | -5.33% | -16.93% | 32.52B | ||
| Average | +0.33% | -4.83% | -5.34% | +7.02% | 80.88B | |
| Weighted average by Cap. | +0.32% | -4.94% | -5.48% | +24.79% |
| 2025 | 2026 * | |
|---|---|---|
| Net sales | 2.63B 381M 328M 296M 284M 516M 35.06B 540M 3.5B 1.4B 16.77B 1.43B 1.4B 60.18B | 3.1B 449M 387M 350M 335M 609M 41.38B 637M 4.13B 1.66B 19.79B 1.69B 1.65B 71.04B |
| Net income | 442M 63.92M 55.14M 49.79M 47.72M 86.73M 5.89B 90.68M 588M 236M 2.82B 240M 235M 10.11B | 545M 78.89M 68.05M 61.46M 58.9M 107M 7.27B 112M 726M 291M 3.48B 296M 290M 12.48B |
| Net Debt | - | - |
Employees
2,807
Calendar
03-28 -
Earnings release - Annual 2025
| Date | Price | Change | Volume |
|---|---|---|---|
| 08/03/26 | 31.49 ¥ | -0.51% | 1,934,877 |
| 06/03/26 | 31.65 ¥ | +1.77% | 1,903,866 |
| 05/03/26 | 31.10 ¥ | +0.26% | 1,581,800 |
| 04/03/26 | 31.02 ¥ | -1.05% | 1,929,094 |
| 03/03/26 | 31.35 ¥ | -2.91% | 3,512,852 |
Sell
Buy

Mean consensus
BUY
Number of Analysts
2
Last Close Price
31.49
Average target price
-
Annual profits - Rate of surprise
- Stock Market
- Equities
- 688139 Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
















